These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24112243)

  • 21. The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex.
    Takei S; Ihara H; Togo S; Nakamura A; Fujimoto Y; Watanabe J; Kurokawa K; Shibayama K; Sumiyoshi I; Ochi Y; Iwai M; Okabe T; Chonan M; Misawa S; Ohsaka A; Takahashi K
    BMC Microbiol; 2020 Oct; 20(1):316. PubMed ID: 33076820
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Chen L; Shashkina E; Kurepina N; Calado Nogueira de Moura V; Daley CL; Kreiswirth BN
    Antimicrob Agents Chemother; 2024 May; 68(5):e0017424. PubMed ID: 38557171
    [No Abstract]   [Full Text] [Related]  

  • 23. Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria.
    Greendyke R; Byrd TF
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2019-26. PubMed ID: 18378709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid.
    Wallace RJ; Brown BA; Onyi GO
    Antimicrob Agents Chemother; 1991 Apr; 35(4):773-5. PubMed ID: 2069387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo evaluation of antibiotic activity against Mycobacterium abscessus.
    Lerat I; Cambau E; Roth Dit Bettoni R; Gaillard JL; Jarlier V; Truffot C; Veziris N
    J Infect Dis; 2014 Mar; 209(6):905-12. PubMed ID: 24253289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Activity of cephems and carbapenems against clinically isolated Mycobacterium abscessus].
    Ito K; Hashimoto K; Ogata H
    Kekkaku; 2003 Sep; 78(9):587-90. PubMed ID: 14577345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the β-Lactamase Bla
    Lefebvre AL; Le Moigne V; Bernut A; Veckerlé C; Compain F; Herrmann JL; Kremer L; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096155
    [No Abstract]   [Full Text] [Related]  

  • 28.
    Brown-Elliott BA; Rubio A; Wallace RJ
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycobacterium abscessus from respiratory isolates: activities of drug combinations.
    Cremades R; Santos A; Rodríguez JC; Garcia-Pachón E; Ruiz M; Royo G
    J Infect Chemother; 2009 Feb; 15(1):46-8. PubMed ID: 19280301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense.
    Zhang Z; Lu J; Liu M; Wang Y; Zhao Y; Pang Y
    Int J Antimicrob Agents; 2017 Mar; 49(3):383-386. PubMed ID: 28188830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical isolates of Mycobacterium abscessus in Guangzhou area most possibly from the environmental infection showed variable susceptibility.
    Zhuo FL; Sun ZG; Li CY; Liu ZH; Cai L; Zhou C; Zhang JZ
    Chin Med J (Engl); 2013; 126(10):1878-83. PubMed ID: 23673103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro antimicrobial susceptibility of Mycobacterium abscessus in Korea.
    Park S; Kim S; Park EM; Kim H; Kwon OJ; Chang CL; Lew WJ; Park YK; Koh WJ
    J Korean Med Sci; 2008 Feb; 23(1):49-52. PubMed ID: 18303198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic susceptibility of diverse Mycobacterium abscessus complex strains in New South Wales, Australia.
    Chua KY; Bustamante A; Jelfs P; Chen SC; Sintchenko V
    Pathology; 2015 Dec; 47(7):678-82. PubMed ID: 26517625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Bedaquiline, Alone or in Combination with Imipenem, against Mycobacterium abscessus in C3HeB/FeJ Mice.
    Le Moigne V; Raynaud C; Moreau F; Dupont C; Nigou J; Neyrolles O; Kremer L; Herrmann JL
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32253217
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative drug resistance of Mycobacterium abscessus and M. chelonae isolates from patients with and without cystic fibrosis in the United Kingdom.
    Broda A; Jebbari H; Beaton K; Mitchell S; Drobniewski F
    J Clin Microbiol; 2013 Jan; 51(1):217-23. PubMed ID: 23135941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro susceptibility testing of imipenem-relebactam and tedizolid against 102 Mycobacterium abscessus isolates.
    Burke A; Carter R; Tolson C; Congdon J; Duplancic C; Bursle E; Bell SC; Roberts JA; Thomson R
    Int J Antimicrob Agents; 2023 Oct; 62(4):106938. PubMed ID: 37517624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative activity of cefoxitin, ampicillin/sulbactam, and imipenem against clinical isolates of Escherichia coli and Klebsiella pneumoniae.
    Shungu DL; Ponticas S; Gill CJ
    Clin Ther; 1989; 11(3):315-8. PubMed ID: 2663161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.
    Swenson JM; Wallace RJ; Silcox VA; Thornsberry C
    Antimicrob Agents Chemother; 1985 Dec; 28(6):807-11. PubMed ID: 4083863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminoglycoside-modifying enzymes determine the innate susceptibility to aminoglycoside antibiotics in rapidly growing mycobacteria.
    Maurer FP; Bruderer VL; Castelberg C; Ritter C; Scherbakov D; Bloemberg GV; Böttger EC
    J Antimicrob Chemother; 2015 May; 70(5):1412-9. PubMed ID: 25604746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates.
    Lee MR; Cheng A; Lee YC; Yang CY; Lai CC; Huang YT; Ho CC; Wang HC; Yu CJ; Hsueh PR
    J Antimicrob Chemother; 2012 Jan; 67(1):222-5. PubMed ID: 21980068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.